Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

GE HealthCare to Strengthen AI-Enabled Fetal Ultrasound

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Johnson & Johnson to Acquire Atraverse...

Johnson & Johnson has entered into a definitive agreement...

US Speeds Insurance Coverage for Breakthrough...

A new federal initiative in the United States is...

FDA Flags Nitrosamine Impurity Risk in...

The U.S. Food and Drug Administration (FDA), through its...

GE HealthCare today announced a collaboration with Diagnoly to advance AI-enabled fetal ultrasound by integrating Diagnolyโ€™s Fetoly solution into GE HealthCareโ€™s Voluson womenโ€™s health ultrasound systems. The collaboration focuses on increasing reproducibility, efficiency and diagnostic confidence for prenatal screening exams.

An ultrasound examination is one of the most important tools physicians have to monitor fetal development and detect congenital abnormalities. However, fetal motion, maternal habitus, and user-dependency can adversely impact exam quality. By embedding AI-enabled fetal ultrasound tools into clinical workflows, the collaboration seeks to streamline examinations, reduce clinician workload, and support more standardized assessments.

โ€œAI is redefining whatโ€™s possible in healthcare, and GE HealthCare is at the forefront of this movement, as an industry leader bringing AI-powered innovations to clinicians,โ€ said Gerald Seifriedsberger, General Manager, Womenโ€™s Health Ultrasound, GE HealthCare. โ€œThis collaboration with Diagnoly further expands our ability to integrate advanced AI-based screening support into Voluson ultrasound, helping elevate care for women and their babies.โ€

Fetoly is a real-time AI solution aligned with International Society of Ultrasound in Obstetrics and Gynecology guidelines. It is designed to support fetal heart and brain analysis while continuously verifying exam completeness and quality criteria during scans, strengthening the Voluson portfolio for clinical use.

โ€œObstetric ultrasound remains one of the most powerful, but also complex imaging techniques. As a result, up to 50% of fetal abnormalities remain undetected during pregnancy,โ€ said Ivan Voznyuk, Co-Founder and CEO of Diagnoly. โ€œThe integration of Fetoly into trusted Voluson ultrasound systems reflects our shared commitment to supporting clinicians in real-time with tools that can help improve maternal and fetal outcomes.โ€

Fetoly is U.S. Food and Drug Administration 510(k) cleared and CE marked. The AI application is available as a free trial through the Voluson Solution Store and major mobile app platforms.

MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Johnson & Johnson to Acquire Atraverse Medical Platform

Johnson & Johnson has entered into a definitive agreement...

US Speeds Insurance Coverage for Breakthrough Medical Device

A new federal initiative in the United States is...

FDA Flags Nitrosamine Impurity Risk in Combination Products

The U.S. Food and Drug Administration (FDA), through its...

FDA 510(k) Clearance Granted to Philips Rembra Platform

Philips has secured FDA 510(k) clearance for its Rembra...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป